I. The origin of WHHL rabbits

        Dr. Yoshio Watanabe (1926-2008), a former professor at our institute, discovered a male Japanese white rabbit in 1973 that showed hyperlipidemia despite feeding on a normal standard diet (Exp Anim 1977; 26: 35-42 (Japanese); Bull Azabu Vet Coll 1977; 2: 99-124 (Japanese); Atherosclerosis 1980; 36: 261-268). He confirmed the hyperlipidemia of this rabbit was inherited recessively from its parents.




II. Development of the WHHL rabbit strain

      Dr. Watanabe established this rabbit mutant strain in 1980 and named it WHHL (Watanabe heritable hyperlipidemic) rabbit ( Atherosclerosis 1980; 36: 261-268). After establishment this WHHL rabbit strain, Dr. Watanabe began to distribute WHHL rabbits to many researchers worldwide.
      In this WHHL line, incidence of coronary atherosclerosis was very low despite them showing severe aortic atherosclerosis. Therefore, we had carried out selective breeding between 1980 and 1984 to increase the incidence of coronary atherosclerosis. As a result, the incidence was increased (Atherosclerosis 1985; 56: 71-79).
      However, the degree of coronary lesions was mild. Therefore, we carried out selective breeding between 1985 and 1991 to increase the degree of the coronary stenosis. After the second selective breeding, WHHL rabbits have suffered from severe coronary atherosclerosis (Atherosclerosis 1992; 96: 43-52). Presently this WHHL rabbit strain is called "coronary atherosclerosis-prone WHHL rabbits".
      After retirement of Professor Watanabe at the age limit in 1990, Dr. Masashi Shiomi succeded to his WHHL rabbit colony and his studies. Although coronary atherosclerosis-prone WHHL rabbits suffered from severe coronary stenosis, the incidence of spontaneous myocardial infarction was extremely low which limits their use in the study of myocardial infarction. Since 1994, we have attempted to develop an animal model for spontaneous myocardial infarction by serial and selective breeding of the coronary atherosclerosis-prone WHHL rabbits. After six years of the selective breeding, we developed a new WHHL strain for spontaneous myocardial infarction and designated this myocardial infarction-prone WHHL rabbit strain as the WHHLMI rabbit (Arterioscler Thromb Vasc Biol 2003;23 (7): 1239-1244); Commentary to the International Atherosclerosis Society, IAS Website (http://www.athero.org/comm-index.asp) September 5, 2003.; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189   (See section of "IV. The characteristics of WHHLMI rabbis")



III. Characteristics of WHHL rabbits

1. Lipid metabolism

    1). LDL receptor
        Similar to human Familial Hypercholesterolemia, LDL receptor’s function is genetically reduced in WHHL rabbits and they show hypercholesterolemia (FEBS Lett 1980; 118: 81-84; Eur J Biochem 1981; 118: 557-564; Proc Natl Acad Sci USA 1981; 78: 2268-2272; J Biol Chem 1981; 256: 9789-9792). This defect arises from an in-frame deletion of 12 nucleotides that eliminates four amino acids from the cysteine-rich ligand binding domains of the LDL receptor (Science 1986; 232: 1230-1237). From this mutant gene, although the precursor of LDL receptor proteins are synthesized normally, the maturation of the LDL receptor protein is delayed and is not transported to the cell surface at a normal rate (Mol Biol Med 1983; 1: 353-367).

    2). Plasma lipid level
        In our present WHHL rabbits, the average plasma cholesterol levels are about 1,100 mg/dl when they are below 6 month-old, about 900 mg/dl at 12-month-old, and about 800 mg/dl at 18-month-old. The average plasma triglyceride levels are between 150 and 300 mg/dl. About 70% of the cholesterol is distributed in LDL fractions, and only a few % in HDL fractions.

    3). VLDL secretion from liver
        The rate of accumulation of apoB-100 does not differ in perfusates of liver from normal and WHHL rabbits and little or no apoB-48 is accumulated in VLDL fractions (Proc Natl Acad Sci USA 1983; 80: 6096-6100). Lipoproteins other than VLDL are not secreted from the liver of WHHL rabbits (Proc Natl Acad Sci USA 1983; 80: 6096-6100). An inhibition of the hepatic microsomal triglyceride transfer protein (MTP) activity diminished the VLDL secretion and reduced the plasma LDL levels in homozygous WHHL rabbits. This suggests that MTP inhibitors should have hypolipidemic effects against homozygous familial hypercholesterolemia. (Eur J Pharmacol 2001; 431: 127-131 ).

    4). Enzyme activity
        The plasma CETP activity of WHHL rabbits is about 2 to 3-fold higher compared with normal rabbits (Arteriosclerosis 1986; 6:345-351). Although the LPL activity of WHHL rabbits is similar to heterozygous WHHL rabbits, the HTGL activity is about 2-fold higher compared with the heterozygotes (Biochem J 1990; 272: 647-651).

    5). Chylomicron metabolism
        In a kinetic study of 125I-labeled chylomicrons, the fractional catabolic rate in WHHL rabbits was similar to normal rabbits (Proc Natl Acad Sci USA 1982; 79: 3623-3627).

    6). Low HDL level
        The fractional catabolic rate of HDL apoA-I of WHHL rabbits was about 1.7-fold higher and the synthetic rate was about 50% compared with normal rabbits (Atherosclerosis 1989; 79: 225-230).

    7). Lipid lowering by aging
        The plasma lipid levels of WHHL rabbits are gradually decreased with age (Metabolism 2000; 49: 552-556). The HMG-CoA reductase activity of the liver microsomal fraction is increased above 12 month-old. The ACAT activity is decreased between 2 month-old and 6 month-old and then remains constant. The activity of cholesterol-7a hydroxylase is almost constant. The cholesterol contents in the whole liver and the microsome fraction are constant. The VLDL secretion rate is decreased with age.


2. Atherosclerosis

    1). Aortic lesion
        In our present WHHL rabbits, aortic atherosclerosis is observed grossly from 2 months old despite feeding them a normal standard rabbit chow. The lesions develop first at the orifices of the branches. At 6 month-old, aortic lesions expanded to about 40% of the aortic surface. At 12 month-old, the lesions cover about 70% of the aortic surface. Above 18 month-old, the aortic lesions cover most of the aorta.
        Regarding lesional composition (Arterioscler Thromb 1994; 14: 931-937; J Atheroscler Thromb 1994; 1: 45-52), in early lesions, many macrophages and few SMCs are observed in the intima and some macrophages penetrate into the arterial media.         In transitional lesions observed at about 12 month-old, large foam cells, derived from macrophages, are increased in the deep area of the intima, and a fibromuscular cap covers the surface. Above 18 month-old, cellular components are decreased, but collagen fibers, extracellular lipid accumulation, and cholesterol cleft are increased. In some case, calcium accumulation is also observed in these advanced lesions.

    2). Coronary lesion
        In our oronary atherosclerosis-prone WHHL rabbits (see the section of "Development of the WHHL rabbit strain"), coronary atherosclerosis is observed from 2 month-old despite feeding them a normal standard rabbit chow. The lesions develop mainly at the main stem of the left coronary artery, the origin of the right coronary artery, and the left circumflex arteries. In rabbits, the left circumflex artery is larger and longer than the left anterior descending artery. The average coronary narrowing (% of plaque area in the area surrounding the internal elastic lamina) of the circumflex artery reaches about 50% at 6 month-old, about 70% at 12 month-old, and about 80% above 18 month-old.
        Lesional composition of coronary plaques is relatively fibromuscular compared with the aortic lesions (Arterioscler Thromb 1994; 14: 931-937). However, several WHHL rabbits show macrophage-rich coronary plaques.
        Atherosclerotic coronary arteries exhibited the enhancement in contraction and Ca2+ mobilization in response to serotonin. The 5-HT1B receptor, which is upregulated by atherosclerosis. most likely mediates the augmenting effects of serotonin. (Circulation 2001; 103: 1289-1295)

        Coronary arteries show compensatory outward remodeling and coronary atherosclerosis-prone WHHL rabbits are useful animal for studies sbout coronary remodeling. We demonstarted the novel insights into coronary lumen preservation during progression of coronary atherosclerosis as follows (Coronary Artery Disease 2004 Nov; 15(7): 419-426);
        Prior quantitative analysis of coronary artery compensatory remodeling is limited by individual variation of arterial size and arterial tapering. Therefore, we developed a new analytical method resolving this limitation and analyzed coronary compensatory remodeling using perfusion-fixed coronary arteries of WHHL rabbits, an animal model for spontaneous coronary atherosclerosis. In the new analysis, we evaluated how lumen area or arterial size was changed with accumulating atherosclerotic plaques compared to before plaque developed. The lumen area modestly decreased below 10% cross-sectional narrowing (CSN), remained constant from 10% to 68% CSN, and diminished sharply despite continued remodeling above 70% CSN. Up to 70% CSN, arterial remodeling progressed quantitatively to maintain constant arterial wall shear stress as well as lumen area. Quantitative analysis eliminating the previous limitation provides the novel insight that coronary compensatory remodeling in atherosclerosis maintains lumen size up to 70% CSN in proportion to wall shear stress.

    3). Cerebral lesion
        Although cerebral atherosclerosis was not observed in WHHL rabbits born before 1995, presently, coronary atherosclerosis-prone WHHL rabbits (see the section of "Development of WHHL rabbit strain") spontaneously suffer from cerebral atherosclerosis without inducing hypertension above 9 month-old (Atherosclerosis 2001; 156 (1): 57-66 ). These lesions are mainly observed in the vertebral arteries, the basilar artery, the confluence of vertebral arteries, and the bifurcation of the basilar artery. However, no lesions were observed in the penetrating arteries. The severity of the lesion is relatively mild and the lesion is fibromuscular. The development of cerebral atherosclerosis is not associated with blood pressure in our WHHL rabbits.

    4). Other arterial lesions
        Atherosclerotic lesions are also observed in the pulmonary artery, carotid arteries, renal arteries, mesenteric artery, celiac artery, and other arteries, while atheromatous lesions are not observed in any small arteries. Regarding lesional composition, although the plaque of the pulmonary artery is macrophage-rich, other arteries have fibromuscular plaques.

In addition, many macrophages/foam cells are observed at the aortic valves.


IV. The characteristics of WHHLMI rabbit
(Arterioscler Thromb Vasc Biol 2003;23 (7): 1239-1244); Commentary to the International Atherosclerosis Society, IAS Website (http://www.athero.org/comm-index.asp) September 5, 2003.; Exp Anim 2004; 53 (4): 339-346; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189)

The WHHLMI rabbit is the first rabbit model for spontaneous myocardial infarction.
WHHLMI rabbits started to die suddenly from 11 months old without apparent symptoms. Histological analysis revealed that myocardial infarction was observed in 97% of rabbits that died up to 35 months old.
The myocardial lesions were widely distributed from the left ventricle, right ventricle, and ventricular septum where coronary arteries showed severe coronary stenosis.
Based on the anatomical location, myocardial infarction is classified into subendocardial infarction, intramural infarction, transmural infarction, and subepicardial infarction.
In many WHHLMI rabbits, old myocardial infarction was accompanied by fresh myocardial lesions.
The aortic and coronary plaques progressed markedly compared to the WHHL rabbits before selective breeding. (Exp Anim 2004; 53 (4): 339-346)
In the LCX, 73% of sections showed atheromatous plaques having above 90% lumen area stenosis.
The serum cholesterol levels increased by about 200 mg/dl despite there beeing no changes in the triglyceride levels compared tio the WHHL rabbits before selective breeding. (Exp Anim 2004; 53 (4): 339-346)
There are no gender difference in aortic and coronary atherosclerosis and the incidence of myocardial lesions, although serum cholesterol levels are high in female. (Exp Anim 2004; 53 (4): 339-346)
Relation of the degree of coronary cross sectional narrowing to the onset of myiocardial infarction is more prominent than the relation of serum cholesterol levels. (Exp Anim 2004; 53 (4): 339-346)
Many culprit plaques of the LCX are foam cell-rich that produces a marked lumen stenosis or concentric occlusion. The typical plaques were associated with complicated changes, including calcification and intraplaque hemorrhage. In some lesions, the plaque was extremely fragile they had a thin cap beneath which there were accumulating macrophages and lipid cores but few smooth muscle cells.
Despite such vulnerable plaques, we were unable to detect the real rupture or thrombus formation in any coronary plaques of WHHLMI rabbits. This suggests that factors other than vulnerable plaque may important to plaque rupture.
The electrocardiograms from a WHHLMI rabbit monitored immediately before sudden decease showed the typical change of acute myocardial infarction in humans.
WHHLMI rabbits will contribute to studies of regeneration of cardiac muscle by gene therapy.
WHHLMI rabbits will be useful to study the mechanisms of plaque stability and plaque rupture or acute coronary syndromes can be produced in WHHLMI rabbits through the introduction of other risk factors.





V. Other property

        Xanthomas are developed at the digital joints and skin of WHHL rabbits. Our WHHL rabbits show hyperinsulinemia but plasma glucose levels are normal under a restriction of feeding.


VI. Inheritance mode

    1. Hypercholesterolemia
        Results of crossbreeding of homozygous WHHL rabbits with normal rabbits show that the plasma cholesterol levels of the offsprig are normal. Rabbits with hypercholesterolemia are observed in about half of the offsprig in crossbreeding of homozygous WHHL rabbits with heterozygous WHHL rabbits, and about one-third of offspring in crossbreeding of heterozygous WHHL rabbits with heterozygous WHHL rabbits. In crossbreeding of homozygous WHHL rabbits with homozygous WHHL rabbits, all offspring seffer from hypercholesterolemia. These results indicate that hypercholesterolemia of WHHL rabbits inherits recessively (Bull Azabu Vet Coll 1977; 2: 99-124 (Japanese)). In our preivious experience, the plasma cholestyerol levels were below 300 mg/dl in heterozygous WHHL rabbits and were above 300 mg/dl in the homozgote in a condition of feeding low cholesterol standard chow which contains almost no cholesterol.
        Although the binding activity of the LDL receptor of fibroblasts was normal in heterozygous WHHL rabbits (Eur J Biochem 1981; 118: 557-564), expression of LDL receptor protein is about half of normal in fibroblasts of heterozygous WHHL rabbits (Mol Biol Med 1983; 1: 353-367).

    2. Coronary atherosclerosis
        Every WHHL rabbit does not suffer from coronary atherosclerosis, although the plasma cholesterol levels are similar. Results of selective breeding suggest that development of coronary atherosclerosis is regulated by plural genes (Atherosclerosis 1985; 56: 71-79; Atherosclerosis 1992; 96: 43-52).


VII. Comparison with transgenic or KO mice
    1) Lipid metabolism
      Lipid metabolism of the rabbits resembles humans compared with mice and rats. Regarding lipoproteins secreted from liver, both apoB-48 containing lipoproteins and apoB-100 containing lipoproteins are secreted from the liver of mice and rats, while in humans and rabbits only apoB-100 containing VLDLs are secreted from the liver. In mice and rats, apoB editing enzyme, which stops the synthesis of apoB-100 and produces apoB-48, is expressed not only in the intestine but also in the liver, while in humans and rabbits the apoB editing enzyme is expressed only in the liver. Lipoproteins containing apoB-48 rapidly disappear from the plasma compared with lipoproteins containing apoB-100.
      Regarding the activity of cholesterol ester transfer protein (CETP) in the plasma, CETP plays an important role in the transport of cholesterol ester among lipoproteins in the plasma of humans and rabbits, although this activity is very low in the plasma of mice and rats.
      Regarding hepatic triglyceride lipase (HTGL), this enzyme is bound to the membrane of the hepatic cells in humans and rabbits but not in mice and rats.
      Regarding the response to inhibitors of HMG-CoA reductase, the plasma cholesterol levels are decreased in humans and rabbits but no in mice and rats.

      Therefore, it is suggested that WHHL rabbits are more suitable in research for lipid metabolism than models of mice and rats.

    2) Atherosclerosis
        Mice and rats are resistant to atherosclerosis compared with humans and rabbits.

Difference in lipid metabolism and atherosclerosis among human, rodents, and WHHL / WHHLMI rabbits (PowerPoint file)


VIII. Results of studies using the WHHL/WHHLMI rabbit in our institute
1. Development and improvement of the WHHL rabbit strain
1) We established the WHHL/WHHLMI rabbit strain (Exp Anim 1977; 26: 35-42 (Japanese); Bull Azabu Vet Coll 1977; 2: 99-124 (Japanese); Atherosclerosis 1980; 36: 261-268).
2) We developed coronary atherosclerosis-prone WHHL rabbits, which suffer from cerebral atherosclerosis (Atherosclerosis 2001; 156 (1): 57-66 ) and severe coronary atherosclerosis (Atherosclerosis 1992; 96: 43-52).
3) We developed the WHHLMI rabbits, which suffer from myocardial infarction spontaneously without any interventions (Arterioscler Thromb Vasc Biol 2003; 23 (7): 1239-1244; Commentary to the International Atherosclerosis Society, IAS Website (http://www.athero.org/comm-index.asp) September 5, 2003.; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189).

2. Atherosclerosis of the WHHL/WHHLMI rabbits
1) Cholesterol-rich VLDL is associated with development of atherosclerosis (Atherosclerosis 1992; 96: 43-52).
2) Factors associated with coronary atherosclerosis differ from those of aortic atherosclerosis (Atherosclerosis 1992; 96: 43-52).
3) We established a method of quantitative analysis for lesional composition of atherosclerotic plaques by measurement of positive areas of each lesional component in immunohistochemical staining by computer-assisted color image analysis (Arterioscler Thromb 1994; 14: 931-937).
4) Lesional composition of coronary atherosclerosis is different from aortic atherosclerosis (Arterioscler Thromb 1994; 14: 931-937; J Atheroscler Thromb 1994; 1: 45-52).
5) Some factors other than plasma cholesterol level and blood pressure affect the development of cerebral atherosclerosis (Atherosclerosis 2001; 156 (1): 57-66 ).
6) In WHHLMI rabbits, many culprit plaques of the LCX are foam cell-rich that produces a marked lumen stenosis or concentric occlusion. The typical plaques were associated with complicated changes, including calcification and intraplaque hemorrhage. In some lesions, the plaque was extremely fragile they had a thin cap beneath which there were accumulating macrophages and lipid cores but few smooth muscle cells. (Arterioscler Thromb Vasc Biol 2003; 23 (7): 1239-1244; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189)
7) In the LCX of WHHLMI rabbits, 73% of sections showed atheromatous plaques having above 90% lumen area stenosis.(Arterioscler Thromb Vasc Biol 2003; 23 (7): 1239-1244; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189)
8) The aortic and coronary plaques in WHHLMI rabbits progressed markedly compared to the WHHL rabbits before selective breeding. (Exp Anim 2004; 53 (4): 339-346)
9) In WHHLMI rabbits, there are no gender difference in aortic and coronary atherosclerosis and the incidence of myocardial lesions, although serum cholesterol levels are high in female. (Exp Anim 2004; 53 (4): 339-346)
10) Relation of the degree of coronary cross sectional narrowing to the onset of myiocardial infarction is more prominent than the relation of serum cholesterol levels. (Exp Anim 2004; 53 (4): 339-346; J Atheroscler Thromb 2004 Sep; 11 (4): 184-189)
11) Coronary arteries show compensatory outward remodeling and coronary atherosclerosis-prone WHHL rabbits are useful animal for studies sbout coronary remodeling. We demonstarted the novel insights into coronary lumen preservation during progression of coronary atherosclerosis as follows (Coronary Artery Disease 2004 Nov; 15(7): 419-426);
Prior quantitative analysis of coronary artery compensatory remodeling is limited by individual variation of arterial size and arterial tapering. Therefore, we developed a new analytical method resolving this limitation and analyzed coronary compensatory remodeling using perfusion-fixed coronary arteries of WHHL rabbits, an animal model for spontaneous coronary atherosclerosis. In the new analysis, we evaluated how lumen area or arterial size was changed with accumulating atherosclerotic plaques compared to before plaque developed. The lumen area modestly decreased below 10% cross-sectional narrowing (CSN), remained constant from 10% to 68% CSN, and diminished sharply despite continued remodeling above 70% CSN. Up to 70% CSN, arterial remodeling progressed quantitatively to maintain constant arterial wall shear stress as well as lumen area. Quantitative analysis eliminating the previous limitation provides the novel insight that coronary compensatory remodeling in atherosclerosis maintains lumen size up to 70% CSN in proportion to wall shear stress.

3. Suppression or stabilization of atherosclerosis
1) We demonstrated that lipid lowering therapy can suppress progression of atherosclerosis and improve the stability of atheromatous plaques (Arterioscler Theromb Vasc Biol 1995; 15: 1938-1944; Br J Pharmacol 1999; 126: 961-968; Atherosclerosis 2001; 157 (1):75-84 ;Atherosclerosis 2005 Feb; 178(2): 287-294;IAS Website March 23, 2005).
2) Smooth muscle cells in the atheromatous plaques play an important role in the stabilization of the plaques by formation of a fibromuscular cap (Atherosclerosis 2001; 157 (1):75-84 ) and a decrease in the smooth muscle cell content in the plaques associated with plaque destabilization (Atherosclerosis 2001; 157 (1):75-84 ).
3) Combination treatment with a statin and a bile acid sequestrant showed more prominent hypolipidemic and antiatherosclerotic effects than mono-therapy.(Atherosclerosis 1990; 83: 69-80).
4) Combination treatment with a statin and a thiazolidinedione derivative showed more prominent antiatherosclerotic effects than mono-therapy independent of hypolipidemic effects (Atherosclerosis 1999; 142: 345-353).
5) Although in vitro studies demonstrated that lipophilic statins inhibited proliferation of arterial smooth muscle cells, simvastatin, one of lipophilic statins, did not depress the fibromuscular components in atheromatous plaques and the plaque-stabilizing effects were due to the reduction of macrophages / lipid deposits. (Atherosclerosis 2005 Feb; 178(2): 287-294;IAS Website March 23, 2005).

4. Hypolipidemic therapy
1) An inhibition of the hepatic microsomal triglyceride transfer protein (MTP) activity diminished the VLDL secretion and reduced the plasma LDL levels in homozygous WHHL rabbits. This suggests that MTP inhibitors should have hypolipidemic effects against homozygous familial hypercholesterolemia. (Eur J Pharmacol 2001; 431: 127-131 ).
2) Hypolipidemic effects of statin are due to reduction of secretion rate of VLDL-cholesterol and a decrease of cholesterol content in the VLDL particle ( Metabolism 1994;43: 559-564; Arzneim Forsch/Drug Res 1994; 44: 1154-1156).


IX. The main collaboration studies carried out by collabolation department
1) Transgenic WHHL rabbits: Atherosclerosis 2006 in press Am J Pathol 2005;167(4):1139-1148. ; Cardiovasc Res 2005 Feb; 65(2): 524-534; J Biol Chem 2004 Feb; 279 (9): 7521-7529; J Biol Chem 2002 Dec; 277 (49): 47486-47492; Ann N Y Acad Sci 2001; 947: 362-365; J Lipid Res 2000; 41: 1004-1012
2) Heme oxygenase: Circulation 2001; 104 (15): 1831-1836
3) CSF: Circulation 1999; 99: 2150-2156; Horm Metab Res 1997;29: 507-509; Ann NY Acad Sci 1995; 748: 630-633; Arterioscler Thromb 1994; 14: 1534-1541; Proc Soc Exp Biol Med 1992;200: 240-244; Atherosclerosis 93: 245-254 (1992)
4) MCP-1: Arterioscler Thromb Vasc Biol 2003 Feb; 23 (2): 244-250
5) Oxidized lipoproteins: Arterioscler Thromb Vasc Biol 2002 Dec; 22 (12): 2049-53; J Lipid Res 2001; 42 (11): 1771-1781
6) Antiatherosclerotic effects of statins: Circulation 2001;103: 993-999; Circulation 2001;103 : 276-283
7) Arterial relaxation response: Circulation 2001;103: 1289-1295; J Cardiovasc Pharmacol 2000;36: 622-630; Arterioscler Thromb 1992;12: 99-105; Circ Res 1983;53: 63-71
8) Coronary flow reserve: Jpn Circ J 2000;64: 971-976
9) Insulin-glucose response: Eur J Drug Metab Ph 2001;26 (3): 185-192; Metabolism 1994;43: 360-366
10) Rheological properties of the thoracic aorta: Pro Polm Phys J 1988;16: 733-736
11) Arterial pressure control: J Vet Med Sci 1992;54: 983-987; J Vet Med Sci 1992;54: 669-673; Cardiovasc Res 1986;20: 195-200
12) Lipoprotein metabolism: Am J Pathol 1996; 149: 1831-1838; Atherosclerosis 1994;108: 91-102; Proc Natl Acad Sci USA 1989;86: 665-669; J Lipid Res 1984;25: 246-253; J Biol Chem 1982;257: 7994-8000; Proc Natl Acad Sci USA 1982;79: 5693-5697; Proc Natl Acad Sci USA 1982;79: 3623-3627; Proc Natl Acad Sci USA 1982;79: 3305-3309; J Biol Chem 1981;256: 9789-9792; Proc Natl Acad Sci USA 1981;78: 2268-2272; Eur J Biochem 1981;118: 557-564; FEBS Lett 118: 81-84;
13) Hypolipidemic effects of statins: Biochim Biophys Acta 1995; 1259: 99-104; Japan J Pharmacol 1992;59: 65-70; Biochim Biophys Acta 1986;877: 50-60;
14) Imaging of atherosclerotic plaques: J Nucl Med. 2004 Jul; 45 (7): 1245-1250



Outline of WHHL rabbits